Hypoactive sexual desire disorder

Current Opinion in Obstetrics and Gynecology

Volumn 24, Issue 4, 2012, Pages 215-220

  Davison, Sonia L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

female sexual dysfunction; hypoactive sexual desire disorder; women

Indexed keywords

4 AMINOBUTYRIC ACID; AMFEBUTAMONE; ANDROGEN; ESTRADIOL; FLIBANSERIN; GEPIRONE; OXYTOCIN; PRASTERONE ACETATE; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR; TESTOSTERONE;

ANDROGEN BLOOD LEVEL; ANDROGEN THERAPY; COGNITIVE THERAPY; DISTRESS SYNDROME; DIZZINESS; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FATIGUE; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; LIBIDO; OVARIECTOMY; PRIORITY JOURNAL; REVIEW; SEXUAL FUNCTION; SLEEP DEPRIVATION; SOMNOLENCE; TESTOSTERONE BLOOD LEVEL; VAGINAL DRYNESS;

ADULT; AGE FACTORS; AGED; ANDROGENS; ANXIETY; COGNITIVE THERAPY; FEMALE; HUMANS; INCIDENCE; INTERPERSONAL RELATIONS; LIBIDO; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 84863720719     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e328355847e     Document Type: Review

References (68)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed.; text revision ed. Washington, DC: American Psychiatric Association; 2000.
2. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol 2003; 24:221-229.
3. Burri A, Spector T. Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors. J Sex Med 2011; 8:2420-2430.
4. West SL, D'Aloisio AA, Agans RP, et al. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 2008; 168:1441-1449.
5. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 2006; 3:212-222.
6. Leiblum SR, Koochaki PE, Rodenberg CA, et al. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006; 13:46-56.
7. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the 'true' prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact? J Sex Med 2008; 5:777-787.
8. ISSM Health Policy Statement: hypoactive sexual desire disorder in women. J Sex Med. 2011; 8:1313.
9. Maserejian NN, Shifren J, Parish SJ, et al. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women. J Sex Marital Ther 2012; 38:41-62.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM III-R. 3rd ed. Association. AP, editor. Washington DC; 1980.
11. Lief HI. What's new in sex research? Inhibited sexual desire. Med Aspects Hum Sex 1977; 11:94-95.
12. Kaplan HS. Hypoactive sexual desire. J Sex Marital Ther 1977; 3:3-9.
13. Moynihan R. The making of a disease: female sexual dysfunction. Br Med J 2003; 326:45-47.
14. Brotto LA, Bitzer J, Laan E, et al. Women's sexual desire and arousal disorders. J Sex Med 2010; 7 (1 Pt 2):586-614.
15. Mitchell K, Graham CA. Two challenges for the classification of sexual dysfunction. J Sex Med 2008; 5:1552-1558.
16. Balon R, Wise TN. Update on diagnoses of sexual dysfunctions: controversies surrounding the proposed revisions of existing diagnostic entities and proposed new diagnoses. Adv Psychosom Med 2011; 31:1-15.
17. Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav 2010; 39:221-239.
18. Stuart FM, Hammond DC, Pett MA. Inhibited sexual desire in women. Arch Sex Behav 1987; 16:91-106.
19. Dennerstein L, Alexander JL, Graziottin A. Sexual desire disorder in women. In Porst H, Buvat J, editors. Standard practice in sexual medicine. Oxford: Blackwell Publishing; 2006. pp. 315-319.
20. Dennerstein L, Alexander JL, Kotz K. The menopause and sexual functioning: a review of the population-based studies. Annu Rev Sex Res 2003; 14:64-82.
21. Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med 2005; 2:317-330.
22. Hayes RD, Dennerstein L, Bennett CM, et al. Relationship between hypoactive sexual desire disorder and aging. Fertil Steril 2007; 87:107-112.
23. Murray SH, Milhausen RR. Sexual desire and relationship duration in young men and women. J Sex Marital Ther 2012; 38:28-40.
24. Connor MK, Maserejian NN, De Rogatis L, et al. Sexual desire, distress, and associated factors in premenopausal women: preliminary findings from the hypoactive sexual desire disorder registry for women. J Sex Marital Ther 2011; 37:176-189.
25. Cain VS, Johannes CB, Avis NE, et al. Sexual functioning and practices in a multiethnic study of midlife women: baseline results from SWAN. J Sex Res 2003; 40:266-276.
26. Davis SR, Guay AT, Shifren JL, Mazer NA. Endocrine aspects of female sexual dysfunction. J Sex Med 2004; 1:82-86.
27. Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90:3847-3853.
28. Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 1974; 118:793-798.
29. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. J Am Med Assoc 2005; 294: 91-96.
30. Graham MD, Pfaus JG. Differential regulation of female sexual behaviour by dopamine agonists in the medial preoptic area. Pharmacol Biochem Behav 2010; 97:284-292.
31. Wiedeking C, Ziegler MG, Lake CR. Plasma noradrenaline and dopaminebeta-hydroxylase during human sexual activity. J Psychiatr Res 1979; 15:139-145.
32. Pfaus JG. Pathways of sexual desire. J Sex Med 2009; 6:1506-1533.
33. Blaicher W, Gruber D, Bieglmayer C, et al. The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest 1999; 47:125-126.
34. Argiolas A, Melis MR. The neurophysiology of the sexual cycle. J Endocrinol Invest 2003; 26 (3 Suppl):20-22.
35. Basson R. Pharmacotherapy for women's sexual dysfunction. Expert Opin Pharmacother 2009; 10:1631-1648.
36. Brauer M, van Leeuwen M, Janssen E, et al. Attentional and affective processing of sexual stimuli in women with hypoactive sexual desire disorder. Arch Sex Behav 2011. [Epub ahead of print]
37. Bianchi-Demicheli F, Cojan Y, Waber L, et al. Neural bases of hypoactive sexual desire disorder in women: an event-related FMRI study. J Sex Med 2011; 8:2546-2559.
38. Burri A, Rahman Q, Spector T. Genetic and environmental risk factors for sexual distress and its association with female sexual dysfunction. Psychol Med 2011; 41:2435-2445.
39. Hickey M, Elliott J, Davison SL. Hormone replacement therapy. BMJ 2012; 344:e763.
40. Davison SL, Bell RJ, Lachina M, et al. Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med 2008; 5:1214-1222.
41. The 2012 Hormone Therapy Position Statement of The North American Menopause Society. Menopause 2012; 19:257-271.
42. Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005; CD004509.
43. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006; 13:770-779.
44. Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008; 359:2005-2017.
45. Goldstat R, Briganti E, Tran J, et al. Transdermal testosterone therapy improves well being, mood, and sexual function in premenopausal women. Menopause 2003; 10:390-398.
46. Davis S, Papalia MA, Norman RJ, et al. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med 2008; 148:569-577.
47. Chudakov B, Ben Zion IZ, Belmaker RH. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire. J Sex Med 2007; 4:204-208.
48. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry. Female sexual dysfunction: clinical development of drug products for treatment. Draft guidance. In Center for Drug Evaluation, Research (CDER), editor.; 2000.
49. Davis SR, Braunstein GD. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2012; 9:1134-1148.
50. Davison SL, Davis SR. Androgenic hormones and aging: the link with female sexual function. Horm Behav 2011; 59:745-753.
51. Davis SR, Wolfe R, Farrugia H, et al. The incidence of invasive breast cancer among women prescribed testosterone for low libido. J Sex Med 2009; 6:1850-1856.
52. Nachtigall L, Casson P, Lucas J, et al. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Gynecol Endocrinol 2011; 27:39-48.
53. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343:682-688.
54. White WB, Grady D, Giudice LC, et al. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. Am Heart J 2012; 163:27-32.
55. El-Hage G, Eden JA, Manga RZ. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder. Climacteric 2007; 10:335-343.
56. Panjari M, Davis SR. DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update 2007; 13:239-248.
57. Panjari M, Davis SR. DHEA for postmenopausal women: a review of the evidence. Maturitas 2010; 66:172-179.
58. Clayton AH, Warnock JK, Kornstein SG, et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitorinduced sexual dysfunction. J Clin Psychiatry 2004; 65:62-67.
59. Segraves RT, Clayton A, Croft H, et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004; 24:339-342.
60. Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 2011; 8:15-27.
61. Goldfischer ER, Breaux J, Katz M, et al. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial. J Sex Med 2011; 8:3160-3172.
62. Derogatis LR, Komer L, Katz M, et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study. J Sex Med 2012; 9:1074-1085.
63. Thorp J, Simon J, Dattani D, et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med 2012; 9:793-804.
64. Fabre LF, Brown CS, Smith LC, Derogatis LR. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women. J Sex Med 2011; 8:1411-1419.
65. ter Kuile MM, Both S, van Lankveld JJ. Cognitive behavioral therapy for sexual dysfunctions in women. Psychiatr Clin North Am 2010; 33:595-610.
66. Smith WJ, Beadle K, Shuster EJ. The impact of a group psychoeducational appointment on women with sexual dysfunction. Am J Obstet Gynecol 2008; 198:697e1-697e6; discussion e6-e7.
67. Trudel G, Marchand A, Ravart M, et al. The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sex Relat Ther 2001; 16:145-164.
68. Jones LM, McCabe MP. The effectiveness of an Internet-based psychological treatment program for female sexual dysfunction. J Sex Med 2011; 8:2781-2792.